Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

activated PI3K-delta syndrome News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A pediatric case report highlights a rare instance of Epstein-Barr virus-positive B-cell lymphoproliferative disorder complicated by septic shock in a patient with activated PI3Kδ syndrome. This study contributes to the understanding of the clinical implications of these conditions.

A new review highlights the potential of PI3K/AKT/mTOR inhibitors derived from traditional Chinese medicine for treating activated phosphoinositide 3-kinase δ syndrome. This research could pave the way for novel therapeutic strategies in managing this rare disease.

Not rare diseases news,news about your rare disease.

Earlier

A pediatric case report highlights a rare instance of Epstein-Barr virus-positive B-cell lymphoproliferative disorder complicated by septic shock in a patient with activated PI3Kδ syndrome. This study contributes to the understanding of the clinical implications of these conditions.

A new review highlights the potential of PI3K/AKT/mTOR inhibitors derived from traditional Chinese medicine for treating activated phosphoinositide 3-kinase δ syndrome. This research could pave the way for novel therapeutic strategies in managing this rare disease.

Not rare diseases news,
news about your rare disease.